Harriet de Wit

Active 1976–2024

153
Papers
30,038
Citations
96
h-index
150
i10-index

Citations

Citations per year for Harriet de Wit1977: 5 citations1978: 8 citations1979: 11 citations1980: 16 citations1981: 14 citations1982: 14 citations1983: 18 citations1984: 17 citations1985: 10 citations1986: 12 citations1987: 37 citations1988: 19 citations1989: 33 citations1990: 22 citations1991: 30 citations1992: 40 citations1993: 30 citations1994: 27 citations1995: 36 citations1996: 49 citations1997: 56 citations1998: 60 citations1999: 65 citations2000: 114 citations2001: 59 citations2002: 173 citations2003: 181 citations2004: 204 citations2005: 248 citations2006: 263 citations2007: 261 citations2008: 357 citations2009: 333 citations2010: 342 citations2011: 334 citations2012: 332 citations2013: 310 citations2014: 277 citations2015: 229 citations2016: 246 citations2017: 199 citations2018: 188 citations2019: 686 citations2020: 842 citations2021: 673 citations2022: 463 citations2023: 336 citations2024: 598 citations2025: 190 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,740 citing papers, 40.6% of this breakdownUnited Kingdom: 845 citing papers, 9.2% of this breakdownCanada: 599 citing papers, 6.5% of this breakdownGermany: 454 citing papers, 4.9% of this breakdownNetherlands: 420 citing papers, 4.6% of this breakdownAustralia: 315 citing papers, 3.4% of this breakdownChina: 298 citing papers, 3.2% of this breakdownItaly: 277 citing papers, 3% of this breakdownSwitzerland: 227 citing papers, 2.5% of this breakdownFrance: 224 citing papers, 2.4% of this breakdownSpain: 223 citing papers, 2.4% of this breakdownSweden: 153 citing papers, 1.7% of this breakdown
0%40.6%Other 15.6%

Fields

  • Neuroscience39.6%
  • Medicine29.4%
  • Psychology16.6%
  • Biochemistry, Genetics and Molecular Biology8.1%
  • Decision Sciences1.7%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Other3.8%

Topics

  • Neurotransmitter Receptor Influence on Behavior13.5%
  • Cannabis and Cannabinoid Research4.4%
  • Neural and Behavioral Psychology Studies4%
  • Substance Abuse Treatment and Outcomes3.9%
  • Neuroscience and Neuropharmacology Research3.6%
  • Memory and Neural Mechanisms3%
  • Other67.6%

Coauthors

All papers

Open in search
  1. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gerard Muntané, Sandra Sanchez‐Roige, Frank J.A. van Rooij, Erdogan Taskesen, Yang Wu, Futao Zhang, Adam Auton, Jason D. Boardman, David W. Clark, Andrew Conlin, Conor Dolan, Urs Fischbacher, Patrick J. F. Groenen, Kathleen Mullan Harris, Gregor Hasler, Albert Hofman, M. Arfan Ikram, Sonia Jain, Robert Karlsson, Ronald C. Kessler, Maarten Kooyman, James MacKillop, Minna Männikkö, Carlos Morcillo-Suárez, Matthew B. McQueen, Klaus M. Schmidt, Melissa Smart, Matthias Sutter, Roy Thurik, André G. Uitterlinden, Jon White, Harriet de Wit, Jian Yang, Lars Bertram, Dorret I. Boomsma, Tõnu Esko, Ernst Fehr, David A. Hinds, Magnus Johannesson, Meena Kumari, David Laibson, Patrik K. E. Magnusson, Michelle N. Meyer, Arcadi Navarro, Abraham A. Palmer, Tune H. Pers, Daniëlle Posthuma, Daniel Schunk, Murray B. Stein, Rauli Svento, Henning Tiemeier, Paul R. H. J. Timmers, Patrick Turley, Robert J. Ursano, Gert G. Wagner, James F. Wilson, Jacob Gratten, James J. Lee, David Cesarini, Daniel J. Benjamin, Philipp Koellinger, Jonathan Beauchamp - Nature Genetics 2019 cited by 841

  2. GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Josep Antoni Ramos‐Quiroga, Tomáš Paus, Marta Ribasés, Jaakko Kaprio, Marco P. Boks, Jordana T. Bell, Tim D. Spector, Joel Gelernter, Dorret I. Boomsma, Nicholas G. Martin, Stuart MacGregor, John R. B. Perry, Abraham A. Palmer, Daniëlle Posthuma, Marcus R. Munafò, Nathan A. Gillespie, Eske M. Derks, Jacqueline M. Vink - Nature Neuroscience 2018 cited by 551

  3. Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers

    Authors: , , , , - Biological Psychiatry 2019 cited by 175

  4. Repeated low doses of LSD in healthy adults: A placebo‐controlled, dose–response study

    Authors: , , , , - Addiction Biology 2022 cited by 82

  5. Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity

    Authors: , , , , , , - Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2019 cited by 95

  6. Impulsivity as a determinant and consequence of drug use: a review of underlying processes

    Authors: - Addiction Biology 2008 cited by 1,407

  7. Genetics of caffeine consumption and responses to caffeine

    Authors: , , - Psychopharmacology 2010 cited by 302

  8. Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans

    Authors: , , , , - Neuropsychopharmacology 2012 cited by 248

  9. The latent structure of impulsivity: impulsive choice, impulsive action, and impulsive personality traits

    Authors: , , , , , - Psychopharmacology 2016 cited by 413

  10. Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing

    Authors: , , , , - Neuropsychopharmacology 2014 cited by 141

  11. The reinstatement model of drug relapse: history, methodology and major findings

    Authors: , , , , - Psychopharmacology 2002 cited by 1,625

  12. Rewarding, Stimulant, and Sedative Alcohol Responses and Relationship to Future Binge Drinking

    Authors: , , , - Archives of General Psychiatry 2011 cited by 377

  13. Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder

    Authors: , , , , , - American Journal of Psychiatry 2021 cited by 112

  14. Amping Up Effort: Effects ofd-Amphetamine on Human Effort-Based Decision-Making

    Authors: , , , , - Journal of Neuroscience 2011 cited by 259

  15. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress

    Authors: , , - Drug and Alcohol Dependence 2017 cited by 129

  16. MDMA alters emotional processing and facilitates positive social interaction

    Authors: , - Psychopharmacology 2014 cited by 97

  17. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults

    Authors: , , , , , - Psychopharmacology 2021 cited by 75

  18. The drug effects questionnaire: psychometric support across three drug types

    Authors: , , , , , - Psychopharmacology 2012 cited by 244

  19. Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol

    Authors: , , , , , , , - SLEEP 2016 cited by 146

  20. The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?

    Authors: , , , - Journal of Psychopharmacology 2016 cited by 104

  21. Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others

    Authors: , , - Biological Psychiatry 2010 cited by 247

  22. Regular exercise is associated with emotional resilience to acute stress in healthy adults

    Authors: , - Frontiers in Physiology 2014 cited by 239

  23. Sex differences in impulsive action and impulsive choice

    Authors: , - Addictive Behaviors 2013 cited by 239

  24. Effects of MDMA on sociability and neural response to social threat and social reward

    Authors: , , , - Psychopharmacology 2009 cited by 208